Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients TP Lodise, N Patel, BM Lomaestro, KA Rodvold, GL Drusano Clinical infectious diseases 49 (4), 507-514, 2009 | 664 | 2009 |
Predictors of 30-Day Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: Impact of Delayed Appropriate Antibiotic Selection TP Lodise Jr, N Patel, A Kwa, J Graves, JP Furuno, E Graffunder, ... Antimicrobial agents and chemotherapy 51 (10), 3510-3515, 2007 | 380 | 2007 |
Vancomycin: we can't get there from here N Patel, MP Pai, KA Rodvold, B Lomaestro, GL Drusano, TP Lodise Clinical infectious diseases 52 (8), 969-974, 2011 | 303 | 2011 |
Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis LA Berenbrok, S Tang, N Gabriel, J Guo, N Sharareh, N Patel, S Dickson, ... Journal of the American Pharmacists Association 62 (6), 1816-1822. e2, 2022 | 213 | 2022 |
Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: a national cohort study of Veterans Affairs … NS Britt, EM Potter, N Patel, ME Steed Clinical Infectious Diseases 61 (6), 871-878, 2015 | 143 | 2015 |
The effect of time to antifungal therapy on mortality in Candidemia associated septic shock GP Patel, D Simon, M Scheetz, CW Crank, T Lodise, N Patel American journal of therapeutics 16 (6), 508-511, 2009 | 115 | 2009 |
Comparative effectiveness and safety of standard-, medium-, and high-dose daptomycin strategies for the treatment of vancomycin-resistant enterococcal bacteremia among Veterans … NS Britt, EM Potter, N Patel, ME Steed Clinical Infectious Diseases 64 (5), 605-613, 2017 | 107 | 2017 |
Clinical outcomes in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus bloodstream infection AM Casapao, SN Leonard, SL Davis, TP Lodise, N Patel, DA Goff, ... Antimicrobial agents and chemotherapy 57 (9), 4252-4259, 2013 | 99 | 2013 |
Nonnucleoside reverse transcriptase inhibitor resistance and the role of the second-generation agents J Adams, N Patel, N Mankaryous, M Tadros, CD Miller Annals of Pharmacotherapy 44 (1), 157-165, 2010 | 96 | 2010 |
Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections GW Patel, N Patel, A Lat, K Trombley, S Enbawe, K Manor, R Smith, ... Diagnostic microbiology and infectious disease 64 (2), 236-240, 2009 | 95 | 2009 |
Refining vancomycin protein binding estimates: identification of clinical factors that influence protein binding JM Butterfield, N Patel, MP Pai, TG Rosano, GL Drusano, TP Lodise Antimicrobial agents and chemotherapy 55 (9), 4277-4282, 2011 | 93 | 2011 |
Clinical epidemiology of carbapenem-intermediate or-resistant Enterobacteriaceae N Patel, S Harrington, A Dihmess, B Woo, R Masoud, P Martis, ... Journal of antimicrobial chemotherapy 66 (7), 1600-1608, 2011 | 89 | 2011 |
Identification of optimal renal dosage adjustments for traditional and extended-infusion piperacillin-tazobactam dosing regimens in hospitalized patients N Patel, MH Scheetz, GL Drusano, TP Lodise Antimicrobial agents and chemotherapy 54 (1), 460-465, 2010 | 78 | 2010 |
Retrospective comparison of outcomes, diagnostic value, and complications of percutaneous prolonged drainage versus surgical pericardiotomy of pericardial effusion associated … N Patel, AM Rafique, S Eshaghian, F Mendoza, S Biner, B Cercek, ... The American journal of cardiology 112 (8), 1235-1239, 2013 | 73 | 2013 |
Defining the pharmacist role in the pandemic outbreak of novel H1N1 influenza S Miller, N Patel, T Vadala, J Abrons, J Cerulli Journal of the American Pharmacists Association 52 (6), 763-767, 2012 | 68 | 2012 |
Frequency of recurrence of pericardial tamponade in patients with extended versus nonextended pericardial catheter drainage AM Rafique, N Patel, S Biner, S Eshaghian, F Mendoza, B Cercek, ... The American journal of cardiology 108 (12), 1820-1825, 2011 | 62 | 2011 |
Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor–, protease inhibitor–, and raltegravir … N Patel, S Abdelsayed, M Veve, CD Miller Annals of Pharmacotherapy 45 (3), 317-324, 2011 | 58 | 2011 |
Positive follow-up blood cultures identify high mortality risk among patients with Gram-negative bacteraemia SA Maskarinec, LP Park, F Ruffin, NA Turner, N Patel, EM Eichenberger, ... Clinical Microbiology and Infection 26 (7), 904-910, 2020 | 56 | 2020 |
Cost-effectiveness of early laparoscopic cholecystectomy for mild acute gallstone pancreatitis S Morris, KS Gurusamy, N Patel, BR Davidson Journal of British Surgery 101 (7), 828-835, 2014 | 55 | 2014 |
Desirable characteristics of hepatitis C treatment regimens: a review of what we have and what we need MR Bidell, M McLaughlin, J Faragon, C Morse, N Patel Infectious diseases and therapy 5, 299-312, 2016 | 53 | 2016 |